Original Article
Prognostic value of combined preoperative prognostic nutritional index and neutrophil to lymphocyte ratio in esophageal squamous cell carcinoma
Translational Cancer Research
2020;
9
(9)
:5117-5127
.
(24 September 2020)
The Prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis
Translational Cancer Research
2020;
9
(9)
:5128-5138
.
(24 September 2020)
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients
Translational Cancer Research
2020;
9
(9)
:5139-5146
.
(24 September 2020)
Administration of amifostine in the stage of remission induction can benefit the patients with hematological malignancy in autologous stem cell transplantation: a retrospective study
Translational Cancer Research
2020;
9
(9)
:5147-5154
.
(24 September 2020)
Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder
Translational Cancer Research
2020;
9
(9)
:5155-5165
.
(24 September 2020)
Robot-assisted distal pancreatectomy improves spleen preservation rate versus laparoscopic distal pancreatectomy for benign and low-grade malignant lesions of the pancreas
Translational Cancer Research
2020;
9
(9)
:5166-5172
.
(24 September 2020)
The expression of Fibulin-3 in ovarian cancer and its relationship with prognosis
Translational Cancer Research
2020;
9
(9)
:5173-5181
.
(24 September 2020)
Prognosis of early stage pulmonary mucinous adenocarcinoma with different treatments
Translational Cancer Research
2020;
9
(9)
:5182-5189
.
(24 September 2020)
hsa-miR-195-5p inhibits cell proliferation of human thyroid carcinoma cells via modulation of p21/cyclin D1 axis
Translational Cancer Research
2020;
9
(9)
:5190-5199
.
(24 September 2020)
Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II–III
Translational Cancer Research
2020;
9
(9)
:5200-5208
.
(24 September 2020)
Recombinant virus expressing hIFN‐λ1 (rL‐hIFN‐λ1) has important effects on endoplasmic reticulum stress, autophagy and apoptosis in small cell lung cancer
Translational Cancer Research
2020;
9
(9)
:5209-5217
.
(24 September 2020)
COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
Translational Cancer Research
2020;
9
(9)
:5218-5232
.
(24 September 2020)
Integrated analysis identifies low microRNA-215 expression as associated with a poor prognosis of patients with colorectal cancer through the IKβ-α signaling pathway
Translational Cancer Research
2020;
9
(9)
:5233-5244
.
(24 September 2020)
Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
Translational Cancer Research
2020;
9
(9)
:5245-5254
.
(24 September 2020)
A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with radical cystectomy for bladder cancer
Translational Cancer Research
2020;
9
(9)
:5255-5267
.
(24 September 2020)
Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
Translational Cancer Research
2020;
9
(9)
:5268-5280
.
(24 September 2020)
ERH overexpression is associated with decreased cell migration and invasion and a good prognosis in gastric cancer
Translational Cancer Research
2020;
9
(9)
:5281-5291
.
(24 September 2020)
Prognostic factors, treatment, and outcomes in combined small cell lung cancer: a SEER survey from 2004 to 2015
Translational Cancer Research
2020;
9
(9)
:5292-5303
.
(24 September 2020)
Risk assessment model and nomogram established by differentially expressed lncRNAs for early-stage lung squamous cell carcinoma
Translational Cancer Research
2020;
9
(9)
:5304-5314
.
(24 September 2020)
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
Translational Cancer Research
2020;
9
(9)
:5315-5322
.
(24 September 2020)
Mesenchymal stem cell-derived exosomes carrying microRNA-150 suppresses the proliferation and migration of osteosarcoma cells via targeting IGF2BP1
Translational Cancer Research
2020;
9
(9)
:5323-5335
.
(24 September 2020)
Radical local treatment for stage IV non-small cell lung cancer in older adults: a propensity-score matched analysis of the SEER database
Translational Cancer Research
2020;
9
(9)
:5336-5349
.
(24 September 2020)
shRNA targeting PLK1 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells
Translational Cancer Research
2020;
9
(9)
:5350-5359
.
(24 September 2020)
B7-H7 is a prognostic biomarker in epithelial ovarian cancer
Translational Cancer Research
2020;
9
(9)
:5360-5370
.
(24 September 2020)
Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
Translational Cancer Research
2020;
9
(9)
:5371-5379
.
(24 September 2020)
A microRNA delivery carrier for hepatic carcinoma therapy using layer-by-layer self-assembled mesenchymal stem cells
Translational Cancer Research
2020;
9
(9)
:5380-5389
.
(24 September 2020)
Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
Translational Cancer Research
2020;
9
(9)
:5390-5400
.
(24 September 2020)
Incidence and prognostic factors of hepatoid adenocarcinoma: a population-based analysis
Translational Cancer Research
2020;
9
(9)
:5401-5410
.
(24 September 2020)
Total superior vena cava reconstruction guided by preoperative three-dimensional (3D)-computed tomography bronchography and angiography
Translational Cancer Research
2020;
9
(9)
:5411-5417
.
(24 September 2020)
Knockdown of ferritin heavy chain (FTH) inhibits the migration of prostate cancer through reducing S100A4, S100A2, and S100P expression
Translational Cancer Research
2020;
9
(9)
:5418-5429
.
(24 September 2020)
Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
Translational Cancer Research
2020;
9
(9)
:5430-5436
.
(24 September 2020)
Tumor mutation burden predicts response and survival to immune checkpoint inhibitors: a meta-analysis
Translational Cancer Research
2020;
9
(9)
:5437-5449
.
(24 September 2020)
Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
Translational Cancer Research
2020;
9
(9)
:5450-5458
.
(24 September 2020)
Identification of key biomarkers and potential signaling pathway associated with poor progression of gastric cancer
Translational Cancer Research
2020;
9
(9)
:5459-5472
.
(24 September 2020)
Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
Translational Cancer Research
2020;
9
(9)
:5473-5483
.
(24 September 2020)
Laparoscopic versus open left hemihepatectomy for hepatocellular carcinoma: a propensity score matching analysis
Translational Cancer Research
2020;
9
(9)
:5484-5492
.
(24 September 2020)
TNFRSF12A and a new prognostic model identified from methylation combined with expression profiles to predict overall survival in hepatocellular carcinoma
Translational Cancer Research
2020;
9
(9)
:5493-5507
.
(24 September 2020)
Association between clinicopathological features and prognosis significance of PD-L1 expression in small cell lung cancer patients: a systemic review and meta-analysis
Translational Cancer Research
2020;
9
(9)
:5508-5516
.
(24 September 2020)
A newly improved POSSUM scoring system for prediction of morbidity in patients with pancreaticoduodenectomy
Translational Cancer Research
2020;
9
(9)
:5517-5527
.
(24 September 2020)
Construction of a potential microRNA, transcription factor and mRNA regulatory network in hepatocellular carcinoma
Translational Cancer Research
2020;
9
(9)
:5528-5543
.
(24 September 2020)
Circulating miR-17 as a promising diagnostic biomarker for lung adenocarcinoma: evidence from the Gene Expression Omnibus
Translational Cancer Research
2020;
9
(9)
:5544-5554
.
(24 September 2020)
Super-enhancers modulate interleukin-6 expression and function in cancers
Translational Cancer Research
2020;
9
(9)
:5555-5565
.
(24 September 2020)
Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors
Translational Cancer Research
2020;
9
(9)
:5566-5573
.
(24 September 2020)
Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3
Translational Cancer Research
2020;
9
(9)
:5574-5584
.
(24 September 2020)
Serum zinc level and tissue ZIP4 expression are related to the prognosis of patients with stages I–III colon cancer
Translational Cancer Research
2020;
9
(9)
:5585-5594
.
(24 September 2020)
Expression of biogenesis of ribosomes BRX1 is associated with malignant progression and prognosis in colorectal cancer
Translational Cancer Research
2020;
9
(9)
:5595-5602
.
(24 September 2020)
Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma
Translational Cancer Research
2020;
9
(9)
:5603-5613
.
(24 September 2020)
Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer
Translational Cancer Research
2020;
9
(9)
:5614-5625
.
(24 September 2020)
MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis
Translational Cancer Research
2020;
9
(9)
:5626-5636
.
(24 September 2020)
FAM172A affects cell proliferation and apoptosis not by targeting β-tubulin in HepG2 cells
Translational Cancer Research
2020;
9
(9)
:5637-5644
.
(24 September 2020)
Review Article
Ramucirumab in the second-line treatment of metastatic colorectal cancer: a narrative review of literature from clinical trials
Translational Cancer Research
2020;
9
(9)
:5645-5654
.
(24 September 2020)
A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignancies
Translational Cancer Research
2020;
9
(9)
:5655-5662
.
(24 September 2020)
Case Report
Primary synovial sarcoma of the duodenal bulb: a case report and review of the literature
Translational Cancer Research
2020;
9
(9)
:5663-5673
.
(24 September 2020)
Huge mesenteric fibromatosis presenting with intestinal perforation and acute diffuse peritonitis: a case report
Translational Cancer Research
2020;
9
(9)
:5674-5678
.
(24 September 2020)
Accessory spleen after splenectomy mimicking adrenal tumor: a case report
Translational Cancer Research
2020;
9
(9)
:5679-5683
.
(24 September 2020)
Editorial on Energy Balance, Aging, Obesity, and Cancer1
Apocalyptic horsemen of geriatric oncology
Translational Cancer Research
2020;
9
(9)
:5684-5686
.
(24 September 2020)
Review Article on Energy Balance, Aging, Obesity, and Cancer1
Regulation of aging and cancer by enhanced environmental activation of a hypothalamic-sympathoneural-adipocyte axis
Translational Cancer Research
2020;
9
(9)
:5687-5699
.
(24 September 2020)
Impact of physical activity and energy restriction on immune regulation of cancer
Translational Cancer Research
2020;
9
(9)
:5700-5731
.
(24 September 2020)
p16 a biomarker of aging and tolerance for cancer therapy
Translational Cancer Research
2020;
9
(9)
:5732-5742
.
(24 September 2020)
Association between diabetes, obesity, aging, and cancer: review of recent literature
Translational Cancer Research
2020;
9
(9)
:5743-5759
.
(24 September 2020)
Sarcopenia in aging, obesity, and cancer
Translational Cancer Research
2020;
9
(9)
:5760-5771
.
(24 September 2020)
Editorial on Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy2
Preface to the series on tumor immune microenvironment in cancer progression and cancer therapy
Translational Cancer Research
2020;
9
(9)
:5772-5774
.
(24 September 2020)
Review Article on Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy2
Role of microenvironmental acidity and tumor exosomes in cancer immunomodulation
Translational Cancer Research
2020;
9
(9)
:5775-5786
.
(24 September 2020)
Antitumor effects of targeting myeloid-derived suppressive cells
Translational Cancer Research
2020;
9
(9)
:5787-5797
.
(24 September 2020)
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
Translational Cancer Research
2020;
9
(9)
:5798-5818
.
(24 September 2020)
Disclosure:
1. The series “Energy Balance, Aging, Obesity, and Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Nathan A. Berger served as the unpaid Guest Editor for the series.
2. The series “Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Jia Wei served as the unpaid Guest Editor for the series.
